🇺🇸 FDA
Patent

US 7670767

Genetic alterations associated with cancer

granted A61PA61P35/00A61P35/04

Quick answer

US patent 7670767 (Genetic alterations associated with cancer) held by The Board of Regents of the University of Texas System expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P35/00, A61P35/04